603367 辰欣药业
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.6879.4286.7386.7819.362
总资产报酬率 ROA (%)3.6967.3675.3115.3347.501
投入资产回报率 ROIC (%)4.4468.8786.3996.3318.786

边际利润分析
销售毛利率 (%)57.74758.78855.99555.46357.245
营业利润率 (%)14.01213.2808.9668.84113.191
息税前利润/营业总收入 (%)13.27612.5988.3208.64613.279
净利润/营业总收入 (%)13.22011.7758.6648.82711.904

收益指标分析
经营活动净收益/利润总额(%)92.44999.96895.16173.12078.290
价值变动净收益/利润总额(%)9.1545.6634.24919.76119.898
营业外收支净额/利润总额(%)0.6650.5500.4390.509-0.032

偿债能力分析
流动比率 (X)3.5593.6283.7013.4003.076
速动比率 (X)2.9613.1113.2492.9122.630
资产负债率 (%)19.89121.41521.41220.55622.119
带息债务/全部投入资本 (%)2.9734.5674.5272.4347.628
股东权益/带息债务 (%)3,212.1052,063.5452,078.6953,938.3521,191.259
股东权益/负债合计 (%)400.588364.479365.406386.412352.036
利息保障倍数 (X)-15.996-16.697-12.136-36.002144.962

营运能力分析
应收账款周转天数 (天)65.96558.75854.20147.92554.075
存货周转天数 (天)154.472126.130118.211124.666134.409